Adamas Pharma (ADMS) Tops Q1 EPS by 15c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Adamas Pharma (ADMS) Tops Q1 EPS by 15c

Adamas Reports First Quarter 2021 Financial Results

May 10, 2021 4:02 PM EDT

First quarter 2021 total revenues of $19.3 million, a 33% increase over first quarter 2020

GOCOVRI New paid prescriptions of 590, an 18% increase over first quarter 2020

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today reported financial results for the first quarter ended March 31, 2021, and recent corporate highlights.

Our commercial execution is effectively raising awareness of GOCOVRI and its expanded label, enabling more patients, caregivers and... More